Physician profile
David J Fallaw
NPI 1437370939
$1,171.51
in general payments reported to CMS, 2019-2025
12 companies · $17.16 in 2025
The $17.16 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2022: $864 · 2023: $135 · 2024: $40.95 · 2025: $17.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $192.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $801.27 | 2022 | |
| Beckman Coulter, INC. | $174.96 | 2019-2023 | Dxi 800 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.08 | 2022-2024 | Ofev |
| Janssen Biotech, INC. | $22.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.48 | 2022 | |
| Aurinia Pharma U.S., INC. | $17.80 | 2023 | Lupkynis |
| Ibsa Pharma INC. | $17.19 | 2024 | Tirosint, Licart |
| Amgen INC. | $17.17 | 2019 | |
| Ani Pharmaceuticals, INC. | $17.16 | 2025 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $16.98 | 2023 | Ultomiris |
| Mylan Specialty L.P. | $14.55 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fallaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.